Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

All doses of Eli Lilly & Co.’s blockbuster new drugs to treat diabetes and weight loss are available in the US after more than a year and a half of shortages. The Food and Drug Administration ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Drug giant Eli Lilly says its weight-loss drug tirzepatide ... and lifestyle changes available. In the SURMOUNT-1 trial, Lilly gave nearly 2,000 volunteers with pre-diabetes and obesity or ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

It was only a matter of time until the GLP-1 receptor agonist drugs like ... and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

America's famous drug manufacturer Eli Lilly has launched the weight loss ... Now its availability in India is expected to provide great relief to patients suffering from obesity and type-2 diabetes.

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...